quanfu quanfu

Product Center

/
/
/
Huierkangxin has been selected for the 2024 Jiangsu Province Innovative Pharmaceutical Equipment Special Award List!

Huierkangxin has been selected for the 2024 Jiangsu Province Innovative Pharmaceutical Equipment Special Award List!

  • Categories:Company news
  • Author:
  • Origin:
  • Time of issue:2024-03-08
  • Views:

(Summary description)Recently, the list of innovative drug and device award projects of the special fund for the construction of a strong manufacturing province in Jiangsu Province in 2024 was released, Ab&B Bio-Tech CO.,LTD. JS's self-developed quadrivalent influenza virus subunit vaccine (Huier Kangxin), a new class of drugs, was selected into the list of approved innovative drugs in 2023.

Huierkangxin has been selected for the 2024 Jiangsu Province Innovative Pharmaceutical Equipment Special Award List!

(Summary description)Recently, the list of innovative drug and device award projects of the special fund for the construction of a strong manufacturing province in Jiangsu Province in 2024 was released, Ab&B Bio-Tech CO.,LTD. JS's self-developed quadrivalent influenza virus subunit vaccine (Huier Kangxin), a new class of drugs, was selected into the list of approved innovative drugs in 2023.

  • Categories:Company news
  • Author:
  • Origin:
  • Time of issue:2024-03-08 16:20
  • Views:
Information

Recently, the list of innovative drug and device award projects of the special fund for the construction of a strong manufacturing province in Jiangsu Province in 2024 was released, Ab&B Bio-Tech CO.,LTD. JS's self-developed quadrivalent influenza virus subunit vaccine (Huier Kangxin), a new class of drugs, was selected into the list of approved innovative drugs in 2023.

  

 

As a class 1 new drug of biological products for prevention, Huier Kangxin has its unique influenza virus subunit extraction process technology, which not only ensures the high purity of HA and NA of the four vaccine strains and the safety of the vaccine, but also shows good immunogenicity, and the quality standards of the products are higher than the standards of the Chinese and EU Pharmacopoeia, filling the domestic gap!

  

 

Recently, the Pharmaceutical High-tech Zone (Gaogang District) awarded Ab&B Bio-Tech CO., LTD. to Ab&B Bio-Tech Co., Ltd. at the conference on promoting entrepreneurship and promoting new industrialization. An Youcai, chairman and general manager of JS, was awarded the honorary title of "Top Ten Star Entrepreneurs"! To Ab&B Bio-Tech CO.,LTD. JS fully affirmed the spirit of daring to dare to do and dare to take the initiative in the research and development and industrialization of innovative vaccines for human use!

 

Scan the QR code to read on your phone

Relevant information

Have a project?Get a touch!

Caring for life, protecting health, and making global technological innovation vaccines are the mission of Ab&B Bio

Contact

E-mail:info@abbbio.com.cn
Add:No. 32, Xinglin Road, Medical High-tech Zone, Taizhou City

Copyright © 2022 Ab&B Bio-Tech CO.,LTD.JS All Rights Reserved.   Powered by:www.300.cn
Search